期刊文献+

从风邪论治恶性淋巴瘤 被引量:9

Treatment of Malignant Lymphoma from the Theory of Wind Pathogens
下载PDF
导出
摘要 风邪是恶性淋巴瘤发病中为首、为始的重要因素,并且在其转移中具有媒介传导的作用,故其治疗,应以祛风为法。由于恶性淋巴瘤的形成并非风邪单一因素,所以在祛风的同时,应配合扶正、化痰、祛瘀、解毒等其他治法。在恶性淋巴瘤的早期,正邪交争,正气尚存,邪气强盛,应以祛风攻邪为主,此时风药可及早、多味、足量运用,同时配合化痰、祛瘀、散结等法,甚至采用放、化疗等攻邪手段以增强驱邪之力;在恶性淋巴瘤的中晚期,患者大多正气亏虚,此时应以扶正祛风为主,在扶助正气,顾护脾胃的基础上运用风药,用药以少味、小剂量为宜。另外,用药时还需配伍一定清热、养阴、益气之药,以防风药辛温耗气伤阴之弊。 Wind pathogen is the first and most important factor in the onset of malignant lymphoma,and it has the function of medium transmission in its metastasis. Therefore,its treatment should be based on dispelling wind. Because the formation of malignant lymphoma is not a single factor of wind pathogen,it should be accompanied by other treatments such as strengthening body resistance,eliminating phlegm,removing blood stasis and detoxification. In the early stage of malignant lymphoma,struggle is between vital qi and pathogen,vital qi still exists,and pathogen is strong,so its treatment should be based on dispelling wind and attacking evil. At this time,wind drugs can be used in an early,multi-flavor and sufficient amount. At the same time,it should be combined with the methods of eliminating phlegm,removing blood stasis,dispersing pathogen accumulation,and even the methods of radiation and chemotherapy to attack evil to enhance the power of expelling evil;In the middle and late stages of malignant lymphoma,most patients suffer from deficiency of healthy qi. At this time,strengthening body resistance and expelling wind should be the main methods. Wind drugs should be applied on the basis of supporting vital qi and protecting spleen and stomach. It is advisable to use less flavor and small dosage. In addition,certain heat-clearing,yin-nourishing,and qi-invigorating herbs should be combined to prevent wind-breaking herbs from consuming qi and hurting yin.
作者 裴俊文 孙太振 付槟梵 蒋士卿 盛李里 PEI Junwen;SUN Taizhen;FU Binfan;JIANG Shiqing;SHENG Lili(Cancer Hospital Affiliated to Zhengzhou University,Zhengzhou Henan China 450008;The First Affiliated Hospital to Henan University of Chinese Medicine,Zhengzhou Henan China 450000;The Second Affiliated Hospital to Henan University of Chinese Medicine,Zhengzhou Henan China 450002)
出处 《中医学报》 CAS 2019年第3期471-474,共4页 Acta Chinese Medicine
基金 国家中医临床研究基地业务建设科研专项项目(JDZX2012025) 郑州市科技领军人才项目(131PLJRC668)
关键词 恶性淋巴瘤 风邪 风药 辨证论治 malignant lymphoma wind pathogen wind drugs treatment based on syndrome differentiation
  • 相关文献

参考文献23

二级参考文献221

共引文献1481

同被引文献245

引证文献9

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部